IMPERIAL CHEMICAL IMP FORMS NEW UNIT NEW YORK March Imperial Chemical Industries PLC said it is forming a new U S pharmaceuticals unit called ICI Pharma Combined sales of Imperial s existing Stuart Pharmaceuticals unit and the new ICI Pharma are projected to be billion dlrs in the company said Stuart had sales of mln dlrs Imperial said it plans to introduce several new drugs including diprivan an anaesthetic and zestril a heart drug over the next three years ICI Pharma and Stuart will operate as separate units of ICI Pharmaceuticals Group it said Stuart Pharmaceuticals and ICI Pharma will have sales of approximately mln dlrs about mln dlrs from the new ICI Pharma and mln dlrs from Stuart officials said The combined sales force of about sales people split about equally between the two units will be slightly larger than the existing sales force at Stuart Regulatory approval for the annesthetic diprivan is expected in late while zestril a hypertension and heart drug should be approved in mid or late company officials said Approval for oth new drugs including statil a treatment for diabetic complications is not expected until and the officials said Reuter